Collaborating Center for the WHO Family of International Classifications in China, Beijing, China
Search for other papers by Jingya Zhou in
Google Scholar
PubMed
Collaborating Center for the WHO Family of International Classifications in China, Beijing, China
Search for other papers by Meng Zhang in
Google Scholar
PubMed
Key Laboratory of Endocrinology of National Health Commission of People’s Republic of China, Beijing, China
Search for other papers by Lin Lu in
Google Scholar
PubMed
China Pituitary Disease Registry Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Search for other papers by Xiaopeng Guo in
Google Scholar
PubMed
China Pituitary Disease Registry Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Search for other papers by Lu Gao in
Google Scholar
PubMed
Search for other papers by Weigang Yan in
Google Scholar
PubMed
Clinical Epidemiology Unit, International Epidemiology Network, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Search for other papers by Haiyu Pang in
Google Scholar
PubMed
Collaborating Center for the WHO Family of International Classifications in China, Beijing, China
Search for other papers by Yi Wang in
Google Scholar
PubMed
China Pituitary Disease Registry Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Search for other papers by Bing Xing in
Google Scholar
PubMed
on the presence of clinical characteristics combined with at least one altered biochemical test, such as 24-h urinary free cortisol level, serum cortisol diurnal variation and the 1 mg overnight low-dose dexamethasone suppression test (LDDST). The
Search for other papers by Natacha Driessens in
Google Scholar
PubMed
Search for other papers by Madhu Prasai in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Christophe De Block in
Google Scholar
PubMed
Search for other papers by Eva Van Caenegem in
Google Scholar
PubMed
Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed
Search for other papers by Frank Nobels in
Google Scholar
PubMed
Search for other papers by Christophe Ghys in
Google Scholar
PubMed
Search for other papers by Laurent Vroonen in
Google Scholar
PubMed
Search for other papers by Corinne Jonas in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
criteria: (i) a simultaneous serum level cortisol below and a plasma ACTH 2-fold above reference ranges; (ii) a high plasma ACTH concentration with a failed cortisol response (<400 nmol/L) to 250 µg intravenous ACTH injection and/or (iii) chronic treatment
Search for other papers by Dan Liang in
Google Scholar
PubMed
Search for other papers by Han Chen in
Google Scholar
PubMed
Search for other papers by Li-Yong Zhong in
Google Scholar
PubMed
–pituitary–adrenal axis (HPA): basal cortisol level <3 μg/dL indicated impaired HPA function while the basal cortisol level >15 μg/dL excluded it. If basal cortisol levels ranged from 3 to 15 μg/dL, the circadian rhythm of adrenocorticotropic hormone and cortisol (08
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Sofia Maria Lider Burciulescu in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Monica Livia Gheorghiu in
Google Scholar
PubMed
Search for other papers by Andrei Muresan in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Iuliana Gherlan in
Google Scholar
PubMed
Search for other papers by Attila Patocs in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Corin Badiu in
Google Scholar
PubMed
metastatic disease were CT scans and MRIs. The presence of AI was defined as low morning (08:00–09.00 h) cortisol level (<3 µg/dL) and insufficient cortisol response to a stimulation (Synachten) test at a maximum 1 month post surgery and the need of gluco
Search for other papers by A Daniel Bird in
Google Scholar
PubMed
Search for other papers by Spencer Greatorex in
Google Scholar
PubMed
Search for other papers by David Reser in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Gareth G Lavery in
Google Scholar
PubMed
Search for other papers by Timothy J Cole in
Google Scholar
PubMed
and located on chromosome 1q32–41 in humans, is a bidirectional enzyme but normally acts as an oxidoreductase in vivo to drive formation of the active glucocorticoid cortisol. Located in the endoplasmic reticulum (ER) membrane, it requires NADPH
Endocrinology Department, University Hospital in Krakow, Krakow, Poland
Search for other papers by Aleksandra Gilis-Januszewska in
Google Scholar
PubMed
Endocrinology Department, University Hospital in Krakow, Krakow, Poland
Search for other papers by Łukasz Kluczyński in
Google Scholar
PubMed
Endocrinology Department, University Hospital in Krakow, Krakow, Poland
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
hospitalized patients within 10 days of moderate and severe TBI (based on cortisol level lower than 11 µg/dL) ( 92 ). In another study, Bensalah et al. evaluated 200 patients during the first week after they sustained a TBI. He concluded that 2.8%, 21%, and
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
causes of NAFLD. Hormone Gland of origin Example of disease Cortisol - Pituitary gland (ACTH) - Adrenal gland (cortisol) - Cushing’s disease - Cushing’s syndrome - Exogenous corticoid administration Thyroxine (T4
Search for other papers by Kamran Iqbal in
Google Scholar
PubMed
Search for other papers by Kate Halsby in
Google Scholar
PubMed
Search for other papers by Robert D Murray in
Google Scholar
PubMed
Search for other papers by Paul V Carroll in
Google Scholar
PubMed
Search for other papers by Robert Petermann in
Google Scholar
PubMed
primary AI, a mineralocorticoid analogue (fludrocortisone), with the aim to replace the missing cortisol and aldosterone, respectively. Conventional immediate-release (IR) HC does not replicate the physiological circadian rhythm of endogenous cortisol
Search for other papers by M Langeveld in
Google Scholar
PubMed
Search for other papers by C Y Tan in
Google Scholar
PubMed
Search for other papers by M R Soeters in
Google Scholar
PubMed
Search for other papers by S Virtue in
Google Scholar
PubMed
Search for other papers by G K Ambler in
Google Scholar
PubMed
NIHR/Wellcome Trust Clinical Research Facility, Addenbrookes Hospital, Cambridge, UK
Search for other papers by L P E Watson in
Google Scholar
PubMed
NIHR/Wellcome Trust Clinical Research Facility, Addenbrookes Hospital, Cambridge, UK
Search for other papers by P R Murgatroyd in
Google Scholar
PubMed
Search for other papers by V K Chatterjee in
Google Scholar
PubMed
Search for other papers by A Vidal-Puig in
Google Scholar
PubMed
) were measured by time-resolved fluorescence immunoassay on an AutoDELFIA analyser (Perkin Elmer) using kits from Perkin Elmer. Cortisol level was measured by fluorescence immunoassay on the Siemens Centaur Autoanalyser. A minimum of two quality control
Jawaharlal Nehru Medical College, Belagavi, India
Search for other papers by Manjunath Goroshi in
Google Scholar
PubMed
Search for other papers by Swati S Jadhav in
Google Scholar
PubMed
Search for other papers by Vijaya Sarathi in
Google Scholar
PubMed
Search for other papers by Anurag R Lila in
Google Scholar
PubMed
Search for other papers by Virendra A Patil in
Google Scholar
PubMed
Search for other papers by Ravikumar Shah in
Google Scholar
PubMed
Search for other papers by Priya Hira in
Google Scholar
PubMed
Search for other papers by Rajaram Sharma in
Google Scholar
PubMed
Search for other papers by Shettepppa Goroshi in
Google Scholar
PubMed
Search for other papers by Gwendolyn Fernandes in
Google Scholar
PubMed
Search for other papers by Amey Rojekar in
Google Scholar
PubMed
Search for other papers by Abhay Dalvi in
Google Scholar
PubMed
Search for other papers by Ganesh Bakshi in
Google Scholar
PubMed
Search for other papers by Gagan Prakash in
Google Scholar
PubMed
Search for other papers by Nalini S Shah in
Google Scholar
PubMed
Search for other papers by Tushar R Bandgar in
Google Scholar
PubMed
considered as cortisol secreting, if overnight dexamethasone supressed serum cortisol was ≥1.8 µg/dL. Diagnosis of patients with AM was based on primary tumour histopathology and/or adrenal biopsy. CT protocol Imaging of the abdomen was performed on a